Virological and clinical anti-HBV [hepatitis B virus] efficacy of tenofovir and emtricitabine in antiretroviral naive patients with HIV/HBV co-infection

Trial Profile

Virological and clinical anti-HBV [hepatitis B virus] efficacy of tenofovir and emtricitabine in antiretroviral naive patients with HIV/HBV co-infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Efavirenz; Emtricitabine; Tenofovir disoproxil fumarate; Zidovudine
  • Indications Hepatitis B; HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top